A Fair Shot: It’s Time For Another COVID Booster
September 20, 2023
As we foreshadowed in August, despite our best efforts to forget about COVID, it continues to be a threat to the health of many, especially if you have an underlying chronic disease, a compromised immune system or are at the beginning or later stages of life. In fact, the numbers…
Medicare 101: Reviewing Basics To Prepare For The Upcoming Annual Enrollment Period
September 13, 2023
As you likely know, Medicare is a federal program that provides health insurance to older Americans. Most people think Medicare is incredibly complicated (and it is), but if you break it down into pieces, it’s easier to understand and plan for your needs. In our desire to help you better…
Epidemic Proportions: Have You Been Swept Up In The Loneliness Epidemic?
August 9, 2023
This past April, US Surgeon General Vivek Murthy created quite a stir when he declared that our country suffers from an epidemic of loneliness and isolation. He issued a 70+ page advisory report on the importance of social connection for the health and well-being of our country. Murthy, the author…
Still Going: What’s Happening Now- And Going Forward- With Covid?
August 2, 2023
It may feel like the days of Covid are behind us, but if that’s your perspective (and a June Gallup Poll reported that 64% of Americans believe this), consider yourself misinformed. Because Covid is not only still here, but there appears to even be an increase in cases this summer…
Grief and Growing: Dealing With Grief And Learning To Move Forward
July 19, 2023
None of us escapes loss and death during the course of our lives. Whether it’s the death of a loved one (be it an aging parent, spouse, or even a child), the disintegration of a beloved friendship, or the separation from a cherished occupation, we will all experience feelings of…
A Hope And A Prayer: Who Will Gain Access To The New FDA-Approved Alzheimer’s Treatment?
July 12, 2023
If you or a loved one suffers from mild cognitive impairment or have been diagnosed with early Alzheimer’s Disease, you’ve likely followed the news over the last few months about a new treatment awaiting FDA approval. Well, that FDA approval has arrived: Leqembi, a medication that targets the amyloid plaques…